Core Viewpoint - Zhangjiajie has launched a panoramic drone sightseeing experience, integrating advanced technology into the cultural tourism sector, enhancing visitor experiences and promoting industry transformation [1][4]. Group 1: Experience and Technology - Tourists can control drones to experience a 360-degree view of Zhangjiajie's stunning landscapes, akin to flying in the movie "Avatar" [1]. - Participants wear VR glasses to receive real-time 8K panoramic images transmitted by the drones, allowing them to switch perspectives effortlessly [3]. - The "Yingling Antigravity" drone, the first of its kind to support 8K real-time panoramic transmission, ensures safe and stable flights in Zhangjiajie's complex terrain [3]. Group 2: Industry Impact - The introduction of the panoramic drone project represents a significant innovation in the cultural tourism experience, breaking traditional viewing limitations and enhancing the integration of technology in the tourism industry [4]. - The ongoing reforms in China's low-altitude airspace management and the emergence of new technologies are fostering a closer integration of low-altitude economy and cultural tourism, creating new consumption scenarios [3]. - The project is seen as a forward-looking practice that injects strong technological momentum into the high-quality development of the industry [4].

Group 1: Investment Trends - The investment in the robotics sector remains strong, with significant funding rounds reported in the past week [1] - Medical device investments are also gaining traction, showcasing a robust performance in the healthcare sector [1] - A total of 22 financing events occurred in the domestic primary market from September 22 to September 28, with a total scale of approximately 3.366 billion RMB [1] Group 2: Sector-Specific Financing - The advanced manufacturing sector completed 9 financing rounds, raising over 540 million RMB, while the robotics sector had 5 financing rounds totaling approximately 1.469 billion RMB [3] - The healthcare sector saw significant investments, including a 63 million USD financing round for Haobo Pharmaceutical [8][9] Group 3: Regional Distribution of Financing - The majority of financing events were concentrated in Jiangsu, Guangdong, and Zhejiang provinces, with Jiangsu leading with 17 cases [4] Group 4: Active Investment Institutions - Active investment institutions included Eagle Investment and PwC Capital, each completing 2 financing rounds primarily in the technology and manufacturing sectors [6] Group 5: Notable Company Financing - Suzhou Laisai Intelligent Technology completed a multi-million RMB Pre-B financing round led by Eagle Investment's Star Fund and Xieli Investment [13][14] - Xingmai Innovation secured 1 billion RMB in A+ round financing, led exclusively by Meituan Longzhu [8] - Aifei Biopharmaceutical announced nearly 300 million RMB in B3 financing, aimed at accelerating clinical research for innovative cancer drugs [12]